Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of lower extremity vascular and neurovascular diseases. Our products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. We offer a comprehensive portfolio of treatment options, including the primary interventional technologies used today – peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons.<
ev3 Closes Acquisition of Chestnut Medical Technologies, Inc. - 06/24/09
PLYMOUTH, Minn., June 24, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that it has closed the acquisition of Chestnut Medical Technologies, Inc., a privately held, California-based company focused on developing minimally invasive therapies fo... More >>
ev3 Signs Agreement to Acquire Chestnut Medical Technologies, Inc. - 06/02/09
Acquisition Will Add Unique Products and Technology to ev3
Neurovascular Franchise
Upfront Purchase Price Payment of $75 million and Contingent
Payment of Up to $75 Million
PLYMOUTH, Minn., June 2, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. ... More >>
ev3 Inc. to Present At the Banc of America Securities-Merrill Lynch 2009 Health Care Conference - 05/07/09
PLYMOUTH, Minn., May 7, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the Banc of America Securities-Merrill Lynch 2009 Health Care Conference at 8:40 a.m. Eastern Time on Thursday, May 14, 200... More >>
Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study - 04/30/09
--Largest Study to Date Will Evaluate SilverHawk Plaque Excision System for Treatment of Lower Extremity Peripheral Arterial DiseasePLYMOUTH, Minn., April 30, 2009 /PRNewswire via COMTEX/ -- ev3 Inc. (Nasdaq: EVVV) today announced that the first patients were recently enrolled in the DEFINITIVE LE p... More >>
ev3 Inc. Reports 2009 First Quarter Financial Results - 04/28/09
Constant Currency First Quarter Net Product Sales Increase 10% to
$100.4 million
Achieved First Quarter Non-GAAP Adjusted Earnings Per Share of $0.07
Third Consecutive Quarter of Positive Cash Flow
PLYMOUTH, Minn., April 28, 2009 ... More >>
ev3 Inc. to Report 2009 First Quarter Results and Host Conference Call On April 28, 2009 - 04/21/09
PLYMOUTH, Minn., April 21, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) will release its 2009 first quarter financial results on Tuesday, April 28, 2009, before regular market trading hours.
The company will host a conference call and webcast the same day at 7:30 a.m. Central Time (8:30 a.m.... More >>
ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance - 02/24/09
--Fourth Quarter Net Product Sales Increased 22% Over Fourth Quarter 2007 --Achieved Fourth Quarter Non-GAAP Adjusted Earnings Per Share of $0.08 --Cash and Cash Equivalents Increased by $13.7 Million to $59.7 MillionPLYMOUTH, Minn., Feb 24, 2009 /PRNewswire-FirstCall via COMTEX/ -- ev3 Inc. (Nasdaq... More >>
ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009 - 02/06/09
PLYMOUTH, Minn., Feb 06, 2009 /PRNewswire-FirstCall via COMTEX/ -- ev3 Inc. (Nasdaq: EVVV) will release its 2008 fourth quarter and full-year financial results and its financial guidance for 2009 on Tuesday, Febuary 24, 2009, before regular market trading hours.
The company will host a conference c... More >>
ev3 Inc. Appoints Shawn McCormick as New Sr. Vice President and Chief Financial Officer - 01/09/09
PLYMOUTH, Minn., Jan. 9 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV),
a global endovascular device company, today announced the appointment of Shawn
McCormick as Sr. Vice President and Chief Financial Officer, effective January
19, 2009. Mr. McCormick succeeds Patrick Spangler, who has ... More >>
ev3 Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference - 01/05/09
PLYMOUTH, Minn., Jan. 5 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV)
today announced that Robert Palmisano, president and chief executive officer,
is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference
at 2:00 p.m. Pacific Time on Monday, January 12, 2009 at the Wes... More >>
ev3 Inc. at BMO Capital Markets Focus on Healthcare Conference
Location
New York, NY
All events and dates are subject to change.
July 2009
?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
